Manufacturing Capability Matrix
Finished Dosage Form | Development | Typical Batch Size (range) | Capacity |
---|---|---|---|
Oral tablets - active | Yes | 90 - 450 kg | ~3.5 billion doses/yr |
Oral tablets - placebo | Yes | 90 - 450 kg | |
Capsules - active | Yes | 200 - 500 kg | ~490 million doses/yr |
Capsules - placebo | Yes | 200 - 500 kg | |
Over encapsulation | Yes | 10 - 25 kg | |
Overcoating - Aqueous | Yes | 100-200 kg | |
Overcoating - Solvent | Yes | 100-175 kg | |
Liquid fills | Yes | 1000 - 2000L | ~56 million bottles/yr |
Liquid fills - Unit Dose | Yes | 60 - 2000L | 12 million/cups/yr |
Topicals | Yes | 360-500 kg | ~2 million tubes/yr |
Powder Fill | Yes | 100 - 1000kg | ~12 million bottles/yr |
Fluid bed granulation | Yes | ||
Hi-shear wet granulation | Yes | ||
Direct tablet compression | Yes |
Packaging One of the key benefits of our manufacturing capability is our ability to support packaging for all of the dosage forms that we manufacture. Bottles, blisters, and tubes are all at your disposal for a comprehensive manufacturing partner. Serialization ANI Global source has implemented serialization and is well on our way to be compliant with serialization requirements. Please contact us for more information.
Packaging Matrix | Mass | Configurations | Size/Shape | Materials |
---|---|---|---|---|
Solids Packaging: Bottles | ||||
Tablets | 100 - 1050 mg | 12, 100, 250, 500, 1000 |
Round, Capsule, Elliptical | |
Capsules | 100 - 600 mg | 100, 250, 500, 1000 |
00,0,1,2,3,4 | |
Powder Fill | 3-2000 g | 1 - 5" diameter containers | Round Containers | |
Solids Packaging: Blisters | 4, 7, 10 | Card | Base: PVC, PVC/PVDC, ALCAR, PETG, Polypropylene, Fromable Foils |
|
Lidding: Al lined with PVDC or heat sealable lacquer, Tyvek, Paper coated with sealable lacquer |
||||
Solids Packaging: Blisters | 3 - 1000 mL | Bottle | Round, Square | Plastic, Glass |
Liquid Packaging-Unit Dose | 5 - 30 mL | Cup | square unit dose cups | Plastic |
Semi-Solid Packaging | 2 - 227 g | Tube | Plastic, Laminate, Metal |